Recruiting NA Breast Cancer

New treatment option for Breast Cancer

Official title Prone Positioning CT Scan and Ultrasound Assessing Axillary Lymph Nodes in Patients With Breast Cancer Official Title: Evaluation of Axillary Lymph Nodes Using Prone Positioning Computed Tomography Scan and Ultrasound in Patients With Breast Cancer

ClinicalTrials.gov ID: NCT05346510

What this study is testing

What it's testing
The early diagnosis and evaluation of breast cancer is of great significance to its treatment and prognosis. Among the multiple factors affecting the prognosis, the degree of axillary lymph node metastasis is one of the most vital factors.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 70, women only

You may be able to join if

  • Preoperative chest CT and axillary Doppler ultrasound examination in the prone position
  • Perform ALND
  • Regular post surgery follow-up (short-term and long-term)

You likely can't join if

  • History of other benign or malignant tumors causing axillary lymphadenopathy

The study team makes the final eligibility decision.

Where it's taking place

  • Shenyang, Liaoning, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 70 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Shenyang, Liaoning, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.